Liu HY - Search Results

1

Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.

Chen W, Wang LL, Liu HY, Long L, Li S. Chen W, et al. Among authors: liu hy. Basic Clin Pharmacol Toxicol. 2008 Sep;103(3):240-6. doi: 10.1111/j.1742-7843.2008.00268.x. Epub 2008 Jul 18. Basic Clin Pharmacol Toxicol. 2008. PMID: 18684227 Free article.

2

Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.

Wang LL, Li JJ, Zheng ZB, Liu HY, Du GJ, Li S. Wang LL, et al. Among authors: liu hy. Eur J Pharmacol. 2004 Oct 11;502(1-2):1-10. doi: 10.1016/j.ejphar.2004.07.048. Eur J Pharmacol. 2004. PMID: 15464084

3

C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.

Cheng G, Wang LL, Qu WS, Long L, Cui H, Liu HY, Cao YL, Li S. Cheng G, et al. Among authors: liu hy. Acta Pharmacol Sin. 2005 Dec;26(12):1460-6. doi: 10.1111/j.1745-7254.2005.00240.x. Acta Pharmacol Sin. 2005. PMID: 16297344

4

C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.

Xu C, Wang LL, Liu HY, Zhou XB, Cao YL, Li S. Xu C, et al. Among authors: liu hy. Acta Pharmacol Sin. 2006 Feb;27(2):223-8. doi: 10.1111/j.1745-7254.2006.00263.x. Acta Pharmacol Sin. 2006. PMID: 16412273

5

Modeling and synthesis of non-cyclic derivatives of GPI-1046 as potential FKBP ligands with neurotrophic properties.

Zhao L, Liu H, Wang L, Li S. Zhao L, et al. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4385-90. doi: 10.1016/j.bmcl.2006.05.044. Epub 2006 Jun 5. Bioorg Med Chem Lett. 2006. PMID: 16753298

6

A novel dual peroxisome proliferator-activated receptors alpha and gamma agonist with beneficial effects on insulin resistance and lipid metabolism.

Xu C, Wang LL, Liu HY, Ruan CM, Zhou XB, Cao YL, Li S. Xu C, et al. Among authors: liu hy. Biotechnol Lett. 2006 Jun;28(12):863-8. doi: 10.1007/s10529-006-9013-y. Epub 2006 May 31. Biotechnol Lett. 2006. PMID: 16786270

7

FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.

Zhao L, Huang W, Liu H, Wang L, Zhong W, Xiao J, Hu Y, Li S. Zhao L, et al. J Med Chem. 2006 Jul 13;49(14):4059-71. doi: 10.1021/jm0502384. J Med Chem. 2006. PMID: 16821768

8

Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.

Wang X, Lin J, Chen Y, Zhong W, Zhao G, Liu H, Li S, Wang L, Li S. Wang X, et al. Bioorg Med Chem. 2009 Mar 1;17(5):1898-904. doi: 10.1016/j.bmc.2009.01.050. Epub 2009 Jan 29. Bioorg Med Chem. 2009. PMID: 19223187

9

P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.

Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S. Chen W, et al. Among authors: liu hy. Br J Pharmacol. 2009 Jul;157(5):724-35. doi: 10.1111/j.1476-5381.2009.00231.x. Epub 2009 May 5. Br J Pharmacol. 2009. PMID: 19422369 Free PMC article.

10

[Establishment of a diabetic-hypertensive rat model].

Zhang B, Cheng G, Liu HY, Wang LL, Li S. Zhang B, et al. Among authors: liu hy. Yao Xue Xue Bao. 2009 Jun;44(6):575-80. Yao Xue Xue Bao. 2009. PMID: 19806885 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,587 results

Search Page

Filters